UBS Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.8M | Buy |
62,100
+30,800
| +98% | +$11M | ﹤0.01% | 2497 |
|
|
2025
Q4 | $10.2M | Sell |
31,300
-19,800
| -39% | -$6.28M | ﹤0.01% | 3263 |
|
|
2025
Q3 | $14.4M | Sell |
51,100
-15,700
| -24% | -$4.55M | ﹤0.01% | 2919 |
|
|
2025
Q2 | $18.7M | Buy |
66,800
+58,100
| +668% | +$16.5M | ﹤0.01% | 2435 |
|
|
2025
Q1 | $2.71M | Sell |
8,700
-99,400
| -92% | -$29.4M | ﹤0.01% | 4420 |
|
|
2024
Q4 | $28.2M | Sell |
108,100
-88,800
| -45% | -$26.3M | 0.01% | 1973 |
|
|
2024
Q3 | $63.4M | Buy |
196,900
+42,400
| +27% | +$13.9M | 0.01% | 1004 |
|
|
2024
Q2 | $48.3M | Buy |
154,500
+21,700
| +16% | +$6.38M | 0.01% | 1057 |
|
|
2024
Q1 | $37.8M | Sell |
132,800
-219,277
| -62% | -$64.2M | 0.01% | 1221 |
|
|
2023
Q4 | $101M | Sell |
352,077
-60,323
| -15% | -$16.4M | 0.03% | 568 |
|
|
2023
Q3 | $111M | Sell |
412,400
-244,500
| -37% | -$61M | 0.04% | 463 |
|
|
2023
Q2 | $146M | Buy |
656,900
+402,600
| +158% | +$93.4M | 0.05% | 363 |
|
|
2023
Q1 | $61.5M | Sell |
254,300
-64,500
| -20% | -$15.8M | 0.02% | 679 |
|
|
2022
Q4 | $83.7M | Buy |
318,800
+91,100
| +40% | +$24.4M | 0.03% | 558 |
|
|
2022
Q3 | $51.3M | Buy |
227,700
+19,200
| +9% | +$4.65M | 0.02% | 677 |
|
|
2022
Q2 | $50.7M | Buy |
208,500
+9,800
| +5% | +$2.4M | 0.02% | 727 |
|
|
2022
Q1 | $48M | Buy |
198,700
+7,100
| +4% | +$1.63M | 0.02% | 865 |
|
|
2021
Q4 | $43.1M | Buy |
191,600
+64,923
| +51% | +$13.7M | 0.01% | 1054 |
|
|
2021
Q3 | $26.9M | Sell |
126,677
-17,457
| -12% | -$4.02M | 0.01% | 1271 |
|
|
2021
Q2 | $35.1M | Sell |
144,134
-77,400
| -35% | -$19M | 0.01% | 1063 |
|
|
2021
Q1 | $55.1M | Buy |
221,534
+68,134
| +44% | +$16.3M | 0.02% | 786 |
|
|
2020
Q4 | $35.3M | Buy |
153,400
+77,700
| +103% | +$17.9M | 0.01% | 981 |
|
|
2020
Q3 | $19.2M | Buy |
75,700
+10,100
| +15% | +$2.5M | 0.01% | 1191 |
|
|
2020
Q2 | $15.5M | Sell |
65,600
-149,600
| -70% | -$34.1M | 0.01% | 1225 |
|
|
2020
Q1 | $43.6M | Sell |
215,200
-48,500
| -18% | -$10.6M | 0.02% | 604 |
|
|
2019
Q4 | $63.6M | Buy |
263,700
+13,700
| +5% | +$3.02M | 0.02% | 632 |
|
|
2019
Q3 | $48.4M | Buy |
250,000
+115,300
| +86% | +$22.1M | 0.02% | 709 |
|
|
2019
Q2 | $24.8M | Sell |
134,700
-5,900
| -4% | -$1.06M | 0.01% | 1055 |
|
|
2019
Q1 | $26.7M | Sell |
140,600
-77,300
| -35% | -$14.8M | 0.01% | 973 |
|
|
2018
Q4 | $42.4M | Buy |
217,900
+114,700
| +111% | +$22.4M | 0.02% | 666 |
|
|
2018
Q3 | $21.4M | Sell |
103,200
-96,200
| -48% | -$19M | 0.01% | 1160 |
|
|
2018
Q2 | $36.8M | Sell |
199,400
-32,400
| -14% | -$5.73M | 0.02% | 820 |
|
|
2018
Q1 | $39.5M | Sell |
231,800
-11,600
| -5% | -$2.13M | 0.02% | 748 |
|
|
2017
Q4 | $42.3M | Buy |
243,400
+38,300
| +19% | +$6.78M | 0.02% | 743 |
|
|
2017
Q3 | $38.2M | Buy |
205,100
+99,200
| +94% | +$17.6M | 0.02% | 734 |
|
|
2017
Q2 | $18.2M | Sell |
105,900
-8,300
| -7% | -$1.35M | 0.01% | 1094 |
|
|
2017
Q1 | $18.7M | Sell |
114,200
-202,662
| -64% | -$33.7M | 0.01% | 1072 |
|
|
2016
Q4 | $46.3M | Sell |
316,862
-21,234
| -6% | -$3.2M | 0.03% | 587 |
|
|
2016
Q3 | $56.4M | Buy |
338,096
+43,000
| +15% | +$7.27M | 0.03% | 480 |
|
|
2016
Q2 | $44.9M | Buy |
295,096
+17,872
| +6% | +$2.78M | 0.03% | 541 |
|
|
2016
Q1 | $41.6M | Buy |
277,224
+120,706
| +77% | +$17.9M | 0.03% | 533 |
|
|
2015
Q4 | $25.4M | Buy |
156,518
+38,098
| +32% | +$5.99M | 0.02% | 825 |
|
|
2015
Q3 | $16.4M | Sell |
118,420
-32,000
| -21% | -$5.04M | 0.01% | 1029 |
|
|
2015
Q2 | $23.1M | Buy |
150,420
+91,799
| +157% | +$14.7M | 0.02% | 884 |
|
|
2015
Q1 | $9.37M | Sell |
58,621
-91,579
| -61% | -$14.4M | 0.01% | 1528 |
|
|
2014
Q4 | $23.9M | Buy |
+150,200
| New | +$23.4M | 0.02% | 889 |
|
Other funds holding AMGN
VCM
VPM
UBS Group's AMGN Position: Q1 2026 in Review
UBS Group reduced its Amgen (AMGN) stake by 23% in Q1 2026, selling an estimated $341M and leaving 3,148,040 shares worth $1.11B. The position accounts for 0.17% of the portfolio, ranked #116.
UBS Group first reported a position in AMGN in Q4 2014 and has held it in 46 quarters since. The position peaked at $1.4B in Q1 2025. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- UBS Group held 3,148,040 shares of Amgen worth $1.11B as of Q1 2026.
- UBS Group sold 956,484 Amgen shares in Q1 2026, an estimated $341M.
- Amgen made up 0.17% of UBS Group's portfolio in Q1 2026, its #116 holding.
- UBS Group first reported a position in Amgen in Q4 2014 and has held it in 46 quarters since.
- UBS Group's Amgen position peaked at $1.4B in Q1 2025.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.